Insiders · Profile

Schilke Tobin

Chief Financial Officer at Crinetics Pharmaceuticals. Filing since 3 Mar 2026. CIK 0001678984

Company
Date
Role
Action
Shares
Amount
Of holding
3 Mar 2026
Chief Financial Officer
Sold on a plan
6,713
$266.30K
7.9%
1 decision on file.